| __timestamp | ACADIA Pharmaceuticals Inc. | BeiGene, Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 6930000 |
| Thursday, January 1, 2015 | 90804000 | 7311000 |
| Friday, January 1, 2016 | 186456000 | 20097000 |
| Sunday, January 1, 2017 | 255062000 | 62602000 |
| Monday, January 1, 2018 | 265758000 | 195385000 |
| Tuesday, January 1, 2019 | 325638000 | 388249000 |
| Wednesday, January 1, 2020 | 388661000 | 600176000 |
| Friday, January 1, 2021 | 396028000 | 990123000 |
| Saturday, January 1, 2022 | 369090000 | 1277852000 |
| Sunday, January 1, 2023 | 402466000 | 1504501000 |
Infusing magic into the data realm
In the competitive world of biopharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for operational efficiency. This analysis compares BeiGene, Ltd. and ACADIA Pharmaceuticals Inc. over a decade, from 2014 to 2023. BeiGene, a global biotechnology company, has seen its SG&A expenses skyrocket by over 21,600%, from a modest $6.93 million in 2014 to a staggering $1.5 billion in 2023. Meanwhile, ACADIA Pharmaceuticals, a leader in developing innovative therapies, experienced a more moderate increase of approximately 1,130%, with expenses rising from $32.7 million to $402.5 million in the same period. This stark contrast highlights BeiGene's aggressive expansion strategy, while ACADIA's steady growth reflects a more conservative approach. Understanding these trends provides valuable insights into each company's strategic priorities and market positioning.
Johnson & Johnson vs ACADIA Pharmaceuticals Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Zoetis Inc. and BeiGene, Ltd.
BeiGene, Ltd. and Exelixis, Inc.: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Viking Therapeutics, Inc.
Breaking Down SG&A Expenses: Blueprint Medicines Corporation vs ACADIA Pharmaceuticals Inc.
Comparing SG&A Expenses: Corcept Therapeutics Incorporated vs ACADIA Pharmaceuticals Inc. Trends and Insights
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MorphoSys AG
Who Optimizes SG&A Costs Better? ACADIA Pharmaceuticals Inc. or MannKind Corporation
Cost Management Insights: SG&A Expenses for ACADIA Pharmaceuticals Inc. and Geron Corporation
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and BioCryst Pharmaceuticals, Inc.
ACADIA Pharmaceuticals Inc. vs Taro Pharmaceutical Industries Ltd.: SG&A Expense Trends